Unintended Consequences of Metric Changes

Panelists discuss how replacing outcome-driven low-density lipoprotein (LDL) targets with process-based statin-use measures led to unintended negative consequences. Clinicians began meeting performance goals without necessarily improving patient outcomes.

They note that the lack of specific targets fostered complacency and variability in practice standards. Health systems measured success by statin prescription rates rather than LDL reduction or cardiovascular prevention.

Panelists conclude that quality measures must prioritize outcomes over process metrics to restore the focus on meaningful patient improvements.